Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity - Wikidata - awgldk - TriplyDB

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

http://www.wikidata.org/entity/Q28344371

about

IgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infection Atherosclerosis I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease The Homophilic Domain - An Immunological Archetype Natural Antibodies as Rheostats for Susceptibility to Chronic Diseases in the Aged B cells with regulatory properties in transplantation tolerance The analysis of clonal expansions in normal and autoimmune B cell repertoires The role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosis The influence of innate and adaptive immune responses on atherosclerosis Natural IgM: beneficial autoantibodies for the control of inflammatory and autoimmune disease Interleukin-5 supports the expansion of fas ligand-expressing killer B cells that induce antigen-specific apoptosis of CD4(+) T cells and secrete interleukin-10 Protective natural autoantibodies to apoptotic cells: evidence of convergent selection of recurrent innate-like clones Inflammatory mediators in vascular disease: identifying promising targets for intracranial aneurysm research Autoreactivity by design: innate B and T lymphocytes Surfactant Lipids at the Host-Environment Interface. Metabolic Sensors, Suppressors, and Effectors of Inflammatory Lung Disease Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity The innate immune response to products of phospholipid peroxidation Generation and biological activities of oxidized phospholipids Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus Selection of apoptotic cell specific human antibodies from adult bone marrow Regulation of Transcription Factors by Reactive Oxygen Species and Nitric Oxide in Vascular Physiology and Pathology.Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance.B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation.B cell subsets in atherosclerosis.Actin polymerization in macrophages in response to oxidized LDL and apoptotic cells: role of 12/15-lipoxygenase and phosphoinositide 3-kinase.Noninvasive diagnosis of ruptured peripheral atherosclerotic lesions and myocardial infarction by antibody profiling Novel antibody markers of unstable atherosclerotic lesions.Pulsed high-dose dexamethasone improves interleukin 10 secretion by CD5+ B cells in patients with primary immune thrombocytopenia.Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins.The lupus susceptibility locus Sle3 is not sufficient to accelerate atherosclerosis in lupus-susceptible low density lipoprotein receptor-deficient mice.Vaccine against arteriosclerosis: an update.Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury.Innate and adaptive immunity in atherosclerosis.B cells and humoral immunity in atherosclerosis T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses Naturally occurring human plasminogen, like genetically related apolipoprotein(a), contains oxidized phosphatidylcholine adducts.Inflammatory pain control by blocking oxidized phospholipid-mediated TRP channel activation.Immune recognition of OxLDL in atherosclerosis.

P2860

Q24631904-F67D69FF-40A6-4F8A-8521-9DC17587A118 Q24644573-CD037834-5C9F-4803-A084-F5EF82B4B6FF Q24673242-9888A270-DCD2-48E8-8FEA-62565A1598E3 Q26745015-4EBBF9B0-F0F4-4C9E-ACAD-6F77D1C02E2D Q26752282-5995C9F5-D41F-4FBD-9868-2E16E26F6FE0 Q26752508-6B958410-214E-44A7-8C3C-C68BB50FC87E Q26771404-BA809BCB-5D39-458C-AB08-6236F04305DA Q26801600-8346195C-B846-4372-96B7-572FD8280C55 Q26996707-F34644AE-4F14-4F3C-B5A4-C05669F3C76E Q27000370-2CBD6A0E-6363-41F7-A69F-8C5C43A59038 Q27021242-F8358E02-59F1-4D60-B017-36A6904C4935 Q27310464-760210F5-E985-494D-9688-D62851D01776 Q28081863-CD0E63DD-923D-46D4-9DEF-E2B9846FA8FD Q28084855-DA47AA35-D237-4646-9FEC-E51C22EB2F29 Q28208367-43DDB5B0-05A0-40B3-B434-CFB81D9B56CD Q28383936-4D8C16EB-8175-4A77-BD36-3DC095178E53 Q28385358-DCDD09B1-E439-48A7-A907-29815CF273A9 Q28389385-2B2FBE67-0361-47D0-AD7B-E8502AE47823 Q28389691-F4F96587-DB06-4A26-A0CE-9EF89F5C4BD0 Q28591255-4BBE0753-F240-422E-9C88-CA980455EC63 Q28658418-50284BFD-DB91-4E2D-BD22-421157C0C488 Q30275422-FB72B99F-E431-4EC9-8716-2AD1A3795439 Q30277362-56AD0135-7801-474C-A143-3542A88CAD46 Q30279171-9E0DFF04-AB04-4326-8525-5D1CD295DB07 Q30413616-E1CD8D31-C3D9-448F-B28D-AC549E2F6B07 Q30423324-2C07CD97-29A2-4325-A55D-663DE16F4A21 Q30480611-8BCDD7AC-E057-4792-BDA0-0F47B1788814 Q33355010-86B58DB2-D2C9-4F34-88F0-9EAA9E7BFD80 Q33355013-D8DF394F-EF54-4683-8726-F848BE9F13CE Q33401624-E5DC9E57-B497-4983-9C2D-EDD96DED78C9 Q33551868-F2164E83-AF51-444E-B4F7-380812A8E6E6 Q33575750-37834B0F-9D49-4D82-94F8-6C7701A2E588 Q33641227-1CC763D8-3C0E-46FA-AD64-0FAB8C9B5575 Q33646877-60556B67-CEBD-4423-B6EC-7E99C8E5C673 Q33659705-17872E94-182A-48A2-BA26-6A9F5D71EFB9 Q33789638-8D080109-038C-4A58-AE72-14FF64E6A63B Q33819043-14F6054F-8308-4B1C-8C28-205275C06FE5 Q33886478-B8991CC9-65A5-45C6-8F59-2E13760168C1 Q33906276-424F8CD3-5622-4B65-8487-D8EE298B03D5 Q33947786-75A113E0-BE9C-4989-BADF-F34D4BBFE64E

P2860

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

http://www.wikidata.org/entity/Q28344371

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Natural antibodies with the T1 ...... rance, and protective immunity

@ast

Natural antibodies with the T1 ...... rance, and protective immunity

@en

Natural antibodies with the T1 ...... rance, and protective immunity

@nl

type

label

Natural antibodies with the T1 ...... rance, and protective immunity

@ast

Natural antibodies with the T1 ...... rance, and protective immunity

@en

Natural antibodies with the T1 ...... rance, and protective immunity

@nl

prefLabel

Natural antibodies with the T1 ...... rance, and protective immunity

@ast

Natural antibodies with the T1 ...... rance, and protective immunity

@en

Natural antibodies with the T1 ...... rance, and protective immunity

@nl

P1433

Q28344371-3EE375FE-4E41-4525-B393-87FA8F361715

P1476

Q28344371-4EA6CCD7-3275-4C9F-9B22-744F948E75A2

P2093

Q28344371-162DDAC6-9FB3-4CAB-8231-2F31DBF0ABC9

Q28344371-4F039918-DF57-4D20-B6C5-01AAA7104DF6

Q28344371-8E497E92-67F7-464E-96B8-2D65556F6633

Q28344371-97EC5674-7BBB-4083-A33A-045EAB5AC674

Q28344371-E448E22A-12B8-43CB-89C9-5A9159DE4C90

Q28344371-E972D6DD-81AD-481E-9C31-B0A784702F1E

Q28344371-F3820C8A-DECA-4212-A3AC-DF23EF1455D6

P2860

Q28344371-02A88767-6133-4CAC-B1B4-A074CDDDBC83

Q28344371-0DABA9E0-D53E-4F5B-997B-73167A9BA3C5

Q28344371-150D9380-3458-4428-867F-1F6F25FFECE8

Q28344371-2143EEE5-8C8A-4BD2-9683-ABA3758F987A

Q28344371-349CFE39-AB14-4E49-BD3C-BBC4971DD679

Q28344371-35524837-9547-4C89-9018-5DFF4AF6B505

Q28344371-3EF3EF4A-FFAB-4028-B11F-75DC65AB518F

Q28344371-42A8B2C4-9C21-4C78-9169-63CEC247F154

Q28344371-44307C82-40A4-469E-8E0D-FCF95D68A3D3

Q28344371-4E151ECF-C8C4-4FA4-A4CC-63AE9E948E51

P304

Q28344371-C50C901B-316C-483B-8F6D-14AF044205C4

P31

Q28344371-70F83C6F-421D-4BCB-9164-1D7B96531ED0

P3181

Q28344371-54338019-74F6-4430-9B5A-648A4C91AE93

P356

Q28344371-14C022D8-C7CC-4167-9FE1-EB1BBC4F2019

P407

Q28344371-7B95D40B-F9B2-4D4D-B5EA-6D65CB800D0C

P433

Q28344371-A1BB2ABA-9F38-4719-A9A6-A0B486091720

P478

Q28344371-18DA3CF4-7DF0-4A69-9091-4D626F37B9E4

P577

Q28344371-1DA7B428-1FF4-4B15-A2F3-D523C961FB9C

P5875

Q28344371-20E93E15-AF14-4C59-9379-583BF98732F9

P698

Q28344371-B88B6494-432B-4FB8-9997-383E80258F1E

P921

Q28344371-0B1A3FC9-2B0D-4850-85A2-74E0A6EBACBA

Q28344371-73B78797-9DB1-45B4-9BD0-275398C08D30

Q28344371-D5BB8FF0-7763-41C4-89A6-F05D2CF4316A

P932

Q28344371-35C50F76-AE75-4315-A55B-391392460297

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Natural antibodies with the T1 ...... rance, and protective immunity

@en

P2093

G J Silverman

http://www.w3.org/2001/XMLSchema#string

J L Witztum

http://www.w3.org/2001/XMLSchema#string

L K Curtiss

http://www.w3.org/2001/XMLSchema#string

M K Chang

http://www.w3.org/2001/XMLSchema#string

P X Shaw

http://www.w3.org/2001/XMLSchema#string

S Hörkkö

http://www.w3.org/2001/XMLSchema#string

W Palinski

http://www.w3.org/2001/XMLSchema#string

P2860

Origin of murine B cell lineages

The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins)

The chosen few? Positive selection and the generation of naive B lymphocytes.

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site

Antigen binding and idiotype analysis of antibodies obtained after electroporation of heavy and light chain genes encoding phosphocholine-specific antibodies: a model for T15-idiotype dominance.

Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae.

Heavy-chain class switch does not terminate somatic mutation.

B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development.

P304

1731-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1023892

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI8472

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2000-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12455587

http://www.w3.org/2001/XMLSchema#string

P698

10862788

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

apoptotic process

P932

378505

http://www.w3.org/2001/XMLSchema#string